News
Researchers have discovered that tirzepatide and semaglutide impact energy metabolism in distinct ways. New animal research ...
Ozempic made headlines. Now its maker faces stock crashes, CEO fallout, and fierce rivalry from Eli Lilly. Discover the trade behind the drama.
Activated Liver-Targeted THR-β Prodrug Demonstrating A Dual Advantage of Fat Reduction and Muscle Preservation ...
FRIDAY, May 16, 2025 (HealthDay News) — Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to ...
Aide to RFK Jr. says White House is pushing for global price parity on GLP-1 drugs for weight loss. Read more here.
New animal research being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May), reveals ...
New animal research being presented at the European Congress on Obesity (ECO25) in Malaga, Spain (11–14 May), reveals distinct metabolic adjustments to tirzepatide and semaglutide treatment, with ...
A head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in ...
In addition to eliciting greater weight loss than Novo Nordisk’s Wegovy, Eli Lilly’s Zepbound does not come at the expense of ...
Editor's note: This article was updated at 1030a with comments from President Trump at a morning news conference and a ...
Our Bureau, Mumbai Monday, May 12, 2025, 14:45 Hrs [IST] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results